KPIs & Operating Metrics(New)
Balance Sheet
Accounts PayablesAccumulated DepreciationAssetsBuildingsCash & EquivalentsCommon EquityConstruction in ProgressGoodwillGoodwill & IntangiblesIntangiblesLand & ImprovementsLiabilities and Shareholders EquityLoans - GrossLoans - Loss AllowanceLoans - NetLong-Term Deferred TaxLong-Term InvestmentsMinority InterestNon-Current DebtOther Non-Current AssetsPayablesReal Estate - GrossReal Estate - NetReceivablesReceivables - AccuredReceivables - NetReceivables - OtherRetained EarningsShareholder's EquityTotal DebtTotal LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Omega Healthcare Investors (OHI) Non-Current Assets (2020 - 2022)

Historic Non-Current Assets for Omega Healthcare Investors (OHI) over the last 3 years, with Q4 2022 value amounting to $453.4 million.

  • Omega Healthcare Investors' Non-Current Assets rose 1709.71% to $453.4 million in Q4 2022 from the same period last year, while for Dec 2022 it was $453.4 million, marking a year-over-year increase of 1709.71%. This contributed to the annual value of $453.4 million for FY2022, which is 1709.71% up from last year.
  • Omega Healthcare Investors' Non-Current Assets amounted to $453.4 million in Q4 2022, which was up 1709.71% from $387.2 million recorded in Q4 2021.
  • Over the past 5 years, Omega Healthcare Investors' Non-Current Assets peaked at $453.4 million during Q4 2022, and registered a low of $387.2 million during Q4 2021.
  • Its 3-year average for Non-Current Assets is $411.9 million, with a median of $395.2 million in 2020.
  • As far as peak fluctuations go, Omega Healthcare Investors' Non-Current Assets crashed by 202.43% in 2021, and later soared by 1709.71% in 2022.
  • Over the past 3 years, Omega Healthcare Investors' Non-Current Assets (Quarter) stood at $395.2 million in 2020, then fell by 2.02% to $387.2 million in 2021, then rose by 17.1% to $453.4 million in 2022.
  • Its Non-Current Assets was $453.4 million in Q4 2022, compared to $387.2 million in Q4 2021 and $395.2 million in Q4 2020.